The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 01, 2022
Filed:
Mar. 17, 2016
Applicant:
Tilt Biotherapeutics Oy, Helsinki, FI;
Inventors:
Akseli Hemminki, Helsinki, FI;
Suvi Parviainen, Helsinki, FI;
Siri Tähtinen, Helsinki, FI;
Ilkka Liikanen, Helsinki, FI;
Mikko Siurala, Helsinki, FI;
Assignee:
TILT Biotherapeutics Oy, Helsinki, FI;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); C07K 16/30 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); C07K 16/28 (2013.01); C07K 16/2809 (2013.01); C07K 16/2821 (2013.01); C07K 16/3092 (2013.01); C12N 15/86 (2013.01); A61K 2039/585 (2013.01); C07K 2317/31 (2013.01); C07K 2317/622 (2013.01); C12N 2710/00044 (2013.01); C12N 2710/00045 (2013.01); C12N 2710/10033 (2013.01); C12N 2710/10332 (2013.01);
Abstract
The present invention relates to the fields of life sciences and medicine. Specifically, the invention relates to cancer therapies of humans. More specifically, the present invention relates to an oncolytic adenoviral vector encoding a bispecific monoclonal antibody. Furthermore, the present invention relates to methods and uses utilizing the oncolytic adenoviral vectors, also together with adoptive cell therapies.